| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |